Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced separate data-sharing deals for digital diabetes management solutions.
Abbott is partnering with Sanofi (NYSE:SNY) to integrate glucose sensing and insulin delivery to help people manage their diabetes. The two companies plan to develop tools to combine Abbott’s FreeStyle Libre technology with insulin dosing information for smart pens, insulin titration apps and cloud software.
And Medtronic said it partnered up with Novo Nordisk (NYSE:NVO) to integrate insulin dosing data from Novo Nordisk’s smart insulin pens into Medtronic’s CGM devices.
Get the full story on our sister site, Drug Delivery Business.